Cargando…

Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus

BACKGROUND: The aim of this study is to develop survival analysis models of hospitalized systemic lupus erythematosus (h-SLE) patients in Jiangsu province using data mining techniques to predict patient survival outcomes and survival status. METHODS: In this study, based on 1999–2009 survival data o...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Linyu, Qu, Wenqiang, Liang, Jun, Kong, Wei, Xu, Xue, Pan, Wenyou, Liu, Lin, Wu, Min, Ding, Fuwan, Hu, Huaixia, Ding, Xiang, Wei, Hua, Zou, Yaohong, Qian, Xian, Wang, Meimei, Wu, Jian, Tao, Juan, Tan, Jun, Da, Zhanyun, Zhang, Miaojia, Li, Jing, Zhang, Huayong, Feng, Xuebing, Chen, Jiaqi, Sun, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263294/
https://www.ncbi.nlm.nih.gov/pubmed/35812398
http://dx.doi.org/10.3389/fimmu.2022.900332
_version_ 1784742701589069824
author Geng, Linyu
Qu, Wenqiang
Liang, Jun
Kong, Wei
Xu, Xue
Pan, Wenyou
Liu, Lin
Wu, Min
Ding, Fuwan
Hu, Huaixia
Ding, Xiang
Wei, Hua
Zou, Yaohong
Qian, Xian
Wang, Meimei
Wu, Jian
Tao, Juan
Tan, Jun
Da, Zhanyun
Zhang, Miaojia
Li, Jing
Zhang, Huayong
Feng, Xuebing
Chen, Jiaqi
Sun, Lingyun
author_facet Geng, Linyu
Qu, Wenqiang
Liang, Jun
Kong, Wei
Xu, Xue
Pan, Wenyou
Liu, Lin
Wu, Min
Ding, Fuwan
Hu, Huaixia
Ding, Xiang
Wei, Hua
Zou, Yaohong
Qian, Xian
Wang, Meimei
Wu, Jian
Tao, Juan
Tan, Jun
Da, Zhanyun
Zhang, Miaojia
Li, Jing
Zhang, Huayong
Feng, Xuebing
Chen, Jiaqi
Sun, Lingyun
author_sort Geng, Linyu
collection PubMed
description BACKGROUND: The aim of this study is to develop survival analysis models of hospitalized systemic lupus erythematosus (h-SLE) patients in Jiangsu province using data mining techniques to predict patient survival outcomes and survival status. METHODS: In this study, based on 1999–2009 survival data of 2453 hospitalized SLE (h-SLE) patients in Jiangsu Province, we not only used the Cox proportional hazards model to analyze patients’ survival factors, but also used neural network models to predict survival outcomes. We used semi-supervised learning to label the censored data and introduced cost-sensitivity to achieve data augmentation, addressing category imbalance and pseudo label credibility. In addition, the risk score model was developed by logistic regression. RESULTS: The overall accuracy of the survival outcome prediction model exceeded 0.7, and the sensitivity was close to 0.8, and through the comparative analysis of multiple indicators, our model outperformed traditional classifiers. The developed survival risk assessment model based on logistic regression found that there was a clear threshold, i.e., a survival threshold indicating the survival risk of patients, and cardiopulmonary and neuropsychiatric involvement, abnormal blood urea nitrogen levels and alanine aminotransferase level had the greatest impact on patient survival time. In addition, the study developed a graphical user interface (GUI) integrating survival analysis models to assist physicians in diagnosis and treatment. CONCLUSIONS: The proposed survival analysis scheme identifies disease-related pathogenic and prognosis factors, and has the potential to improve the effectiveness of clinical interventions.
format Online
Article
Text
id pubmed-9263294
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92632942022-07-09 Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus Geng, Linyu Qu, Wenqiang Liang, Jun Kong, Wei Xu, Xue Pan, Wenyou Liu, Lin Wu, Min Ding, Fuwan Hu, Huaixia Ding, Xiang Wei, Hua Zou, Yaohong Qian, Xian Wang, Meimei Wu, Jian Tao, Juan Tan, Jun Da, Zhanyun Zhang, Miaojia Li, Jing Zhang, Huayong Feng, Xuebing Chen, Jiaqi Sun, Lingyun Front Immunol Immunology BACKGROUND: The aim of this study is to develop survival analysis models of hospitalized systemic lupus erythematosus (h-SLE) patients in Jiangsu province using data mining techniques to predict patient survival outcomes and survival status. METHODS: In this study, based on 1999–2009 survival data of 2453 hospitalized SLE (h-SLE) patients in Jiangsu Province, we not only used the Cox proportional hazards model to analyze patients’ survival factors, but also used neural network models to predict survival outcomes. We used semi-supervised learning to label the censored data and introduced cost-sensitivity to achieve data augmentation, addressing category imbalance and pseudo label credibility. In addition, the risk score model was developed by logistic regression. RESULTS: The overall accuracy of the survival outcome prediction model exceeded 0.7, and the sensitivity was close to 0.8, and through the comparative analysis of multiple indicators, our model outperformed traditional classifiers. The developed survival risk assessment model based on logistic regression found that there was a clear threshold, i.e., a survival threshold indicating the survival risk of patients, and cardiopulmonary and neuropsychiatric involvement, abnormal blood urea nitrogen levels and alanine aminotransferase level had the greatest impact on patient survival time. In addition, the study developed a graphical user interface (GUI) integrating survival analysis models to assist physicians in diagnosis and treatment. CONCLUSIONS: The proposed survival analysis scheme identifies disease-related pathogenic and prognosis factors, and has the potential to improve the effectiveness of clinical interventions. Frontiers Media S.A. 2022-06-24 /pmc/articles/PMC9263294/ /pubmed/35812398 http://dx.doi.org/10.3389/fimmu.2022.900332 Text en Copyright © 2022 Geng, Qu, Liang, Kong, Xu, Pan, Liu, Wu, Ding, Hu, Ding, Wei, Zou, Qian, Wang, Wu, Tao, Tan, Da, Zhang, Li, Zhang, Feng, Chen and Sun https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Geng, Linyu
Qu, Wenqiang
Liang, Jun
Kong, Wei
Xu, Xue
Pan, Wenyou
Liu, Lin
Wu, Min
Ding, Fuwan
Hu, Huaixia
Ding, Xiang
Wei, Hua
Zou, Yaohong
Qian, Xian
Wang, Meimei
Wu, Jian
Tao, Juan
Tan, Jun
Da, Zhanyun
Zhang, Miaojia
Li, Jing
Zhang, Huayong
Feng, Xuebing
Chen, Jiaqi
Sun, Lingyun
Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus
title Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus
title_full Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus
title_fullStr Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus
title_full_unstemmed Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus
title_short Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus
title_sort development and verify of survival analysis models for chinese patients with systemic lupus erythematosus
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263294/
https://www.ncbi.nlm.nih.gov/pubmed/35812398
http://dx.doi.org/10.3389/fimmu.2022.900332
work_keys_str_mv AT genglinyu developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT quwenqiang developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT liangjun developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT kongwei developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT xuxue developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT panwenyou developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT liulin developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT wumin developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT dingfuwan developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT huhuaixia developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT dingxiang developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT weihua developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT zouyaohong developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT qianxian developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT wangmeimei developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT wujian developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT taojuan developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT tanjun developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT dazhanyun developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT zhangmiaojia developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT lijing developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT zhanghuayong developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT fengxuebing developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT chenjiaqi developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus
AT sunlingyun developmentandverifyofsurvivalanalysismodelsforchinesepatientswithsystemiclupuserythematosus